Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikolaj Frost

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
European Journal of Gastroenterology & Hepatology|January 18, 2013
Bezafibrate maintenance therapy in patients with advanced chronic hepatitis CViola Knop, Alexandra Bergk, Beate Schlosser, et al.
Cancers|October 14, 2022
Verification of a Novel Minimally Invasive Device for the Isolation of Rare Circulating Tumor Cells (CTC) in Cancer Patients' BloodPaul Friedrich Geus, Felix Hehnen, Sophia Krakowski, et al.
Clinical Lung Cancer|May 11, 2023
Rationale and Design of the Phase II ANTELOPE Study of Atezolizumab, Carboplatin and nab-Paclitaxel vs. Pembrolizumab, Platinum and Pemetrexed in TTF-1 Negative, Metastatic Lung Adenocarcinoma (AIO-TRK-0122)Nikolaj Frost, Annalen Bleckmann, Frank Griesinger, et al.
BMC Pulmonary Medicine|December 4, 2019
Indwelling pleural catheters for malignancy-associated pleural effusion: report on a single centre's ten years of experienceNikolaj Frost, Martin Brünger, Christoph Ruwwe-Glösenkamp, et al.
BMC Cancer|November 24, 2018
RNA-based analysis of ALK fusions in non-small cell lung cancer cases showing IHC/FISH discordanceClaudia Vollbrecht, Dido Lenze, Michael Hummel, et al.
Diabetes|January 11, 2008
Liver-specific peroxisome proliferator-activated receptor alpha target gene regulation by the angiotensin type 1 receptor blocker telmisartanMarkus Clemenz, Nikolaj Frost, Michael Schupp, et al.
European Journal of Cancer Care|January 16, 2021
Can routine register data be used to identify vulnerable lung cancer patients of suboptimal care in a German comprehensive cancer centre?Kathrin Gödde, Bob Siegerink, Hella Fügemann, et al.
Clinical Lung Cancer|December 17, 2019
Validation of Independent Prognostic Value of Asphericity of <sup>18</sup>F-Fluorodeoxyglucose Uptake in Non-Small-Cell Lung Cancer Patients Undergoing Treatment With Curative IntentJulian M M Rogasch, Christian Furth, Christoph Chibolela, et al.
Clinical Lung Cancer|July 5, 2020
Pemetrexed-Based Chemotherapy Is Inferior to Pemetrexed-Free Regimens in Thyroid Transcription Factor 1 (TTF-1)-Negative, EGFR/ALK-Negative Lung Adenocarcinoma: A Propensity Score Matched Pairs AnalysisNikolaj Frost, Tamar Zhamurashvili, Maximilian von Laffert, et al.
Plos One|June 29, 2023
Feasibility of a patient-oriented navigation programme for patients with lung cancer or stroke in Germany: Protocol of the CoreNAVI studyKathrin Gödde, Hella Fügemann, Ute Goerling, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
European Journal of Gastroenterology & Hepatology|January 18, 2013
Bezafibrate maintenance therapy in patients with advanced chronic hepatitis CViola Knop, Alexandra Bergk, Beate Schlosser, et al.
Cancers|October 14, 2022
Verification of a Novel Minimally Invasive Device for the Isolation of Rare Circulating Tumor Cells (CTC) in Cancer Patients' BloodPaul Friedrich Geus, Felix Hehnen, Sophia Krakowski, et al.
Clinical Lung Cancer|May 11, 2023
Rationale and Design of the Phase II ANTELOPE Study of Atezolizumab, Carboplatin and nab-Paclitaxel vs. Pembrolizumab, Platinum and Pemetrexed in TTF-1 Negative, Metastatic Lung Adenocarcinoma (AIO-TRK-0122)Nikolaj Frost, Annalen Bleckmann, Frank Griesinger, et al.
BMC Pulmonary Medicine|December 4, 2019
Indwelling pleural catheters for malignancy-associated pleural effusion: report on a single centre's ten years of experienceNikolaj Frost, Martin Brünger, Christoph Ruwwe-Glösenkamp, et al.
BMC Cancer|November 24, 2018
RNA-based analysis of ALK fusions in non-small cell lung cancer cases showing IHC/FISH discordanceClaudia Vollbrecht, Dido Lenze, Michael Hummel, et al.
Diabetes|January 11, 2008
Liver-specific peroxisome proliferator-activated receptor alpha target gene regulation by the angiotensin type 1 receptor blocker telmisartanMarkus Clemenz, Nikolaj Frost, Michael Schupp, et al.
European Journal of Cancer Care|January 16, 2021
Can routine register data be used to identify vulnerable lung cancer patients of suboptimal care in a German comprehensive cancer centre?Kathrin Gödde, Bob Siegerink, Hella Fügemann, et al.
Clinical Lung Cancer|December 17, 2019
Validation of Independent Prognostic Value of Asphericity of <sup>18</sup>F-Fluorodeoxyglucose Uptake in Non-Small-Cell Lung Cancer Patients Undergoing Treatment With Curative IntentJulian M M Rogasch, Christian Furth, Christoph Chibolela, et al.
Clinical Lung Cancer|July 5, 2020
Pemetrexed-Based Chemotherapy Is Inferior to Pemetrexed-Free Regimens in Thyroid Transcription Factor 1 (TTF-1)-Negative, EGFR/ALK-Negative Lung Adenocarcinoma: A Propensity Score Matched Pairs AnalysisNikolaj Frost, Tamar Zhamurashvili, Maximilian von Laffert, et al.
Plos One|June 29, 2023
Feasibility of a patient-oriented navigation programme for patients with lung cancer or stroke in Germany: Protocol of the CoreNAVI studyKathrin Gödde, Hella Fügemann, Ute Goerling, et al.
Pageof 7